Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Using Concurrent Carboplatin and Reduced Dose Craniospinal Radiation (24Gy) for Metastatic Medulloblastoma, High-Risk Supratentorial PNET and Metastatic PNET

NCT01542736 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01542736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01542736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Using Concurrent Carboplatin and Reduced Dose Craniospinal Radiation (24Gy) for Metastatic Medulloblastoma, High-Risk Supratentorial PNET and Metastatic PNET
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
September 30, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk supratentorial pnet, metastatic medulloblastoma, metastatic pnet